Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AML

NCT06621212 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory Acute Myeloid Leukaemia
Myeloid Malignancy

Interventions

DRUG: mitoxantrone hydrochloride liposome
DRUG: Cytarabine
DRUG: Venetoclax

Sponsor

First Affiliated Hospital of Zhejiang University

Collaborators

[object Object]